Compounded vs Brand-Name GLP-1: Cost, Legality, and Safety (2026)
Short answer
Brand-name GLP-1s like Wegovy and Zepbound are FDA-approved and were tested in large clinical trials. Compounded semaglutide and tirzepatide are not FDA-approved. A state-licensed pharmacy prepares them for one patient when a licensed prescriber decides it is appropriate. At Surfbound, compounded semaglutide is $169 a month and compounded tirzepatide is $219 a month at every prescribed dose, with provider review and shipping included if prescribed.
If you decide to start
Compounded semaglutide $169/month · tirzepatide $219/month
One flat price at every prescribed dose. No membership fee. Medication and discreet shipping included if prescribed.
The two paths to GLP-1 medication
GLP-1 medications are available through two distinct access pathways: FDA-approved brand-name products (Wegovy, Zepbound) manufactured by pharmaceutical companies and subject to pre-market FDA review, and non-FDA-approved compounded preparations made by licensed compounding pharmacies. They differ fundamentally in regulatory oversight, quality control, cost, and availability.
Brand-name GLP-1 medications
Brand-name GLP-1 medications are FDA-approved products that have undergone extensive pre-market clinical testing and are manufactured in FDA-inspected facilities with standardized quality control. They are the most rigorously studied option, but cash prices are higher without coverage.
- FDA-approved for specific indications based on clinical trial data
- Manufactured in FDA-registered facilities with standardized quality control processes
- Consistent dosing and formulation from batch to batch
- Often expensive without insurance coverage
Compounded GLP-1 medications
Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies pursuant to a provider prescription. They are not FDA-approved (no pre-market review for safety, efficacy, or quality), but compounded medications may be prescribed for an individual patient when clinically appropriate and permitted under applicable federal and state law.
- Not FDA-approved: no pre-market review for safety, efficacy, or quality
- Prepared by state-licensed compounding pharmacies
- Surfbound compounded semaglutide is $169/month and compounded tirzepatide is $219/month, flat at every prescribed dose. Brand-name regular self-pay prices are listed in the table below.
- Compounded medications may be prescribed for an individual patient when clinically appropriate and permitted under applicable federal and state law
- Dosing and formulation can vary between pharmacies
Is compounded GLP-1 still legal in 2026?
FDA's position is that shortage-based compounding has ended and patient-specific compounding remains subject to federal and state rules. During the national shortages of semaglutide and tirzepatide, FDA allowed pharmacies to make copies of the brand-name drugs to fill the gap. FDA determined the semaglutide injection shortage resolved on February 21, 2025, per FDA's alert, and the grace periods for shortage-based compounding ended in 2025.
What remains is patient-specific compounding. A state-licensed 503A pharmacy can prepare a compounded medication for one patient when that patient's prescriber has a clinical reason for it. Large outsourcing facilities (503B) face tighter limits, and on April 30, 2026, FDA proposed keeping semaglutide, tirzepatide, and liraglutide off the list of drugs those facilities can make from bulk ingredients. As of this update, that proposal is not final.
FDA has also sent warning letters to dozens of telehealth companies over misleading compounded GLP-1 marketing, such as calling compounded drugs FDA-approved or the same as a brand-name drug. Compounded GLP-1s are not FDA-approved and are not generics.
At Surfbound, a licensed provider reviews every intake and decides whether a compounded medication is medically appropriate for you. Not everyone qualifies. If you are prescribed, your medication comes from one of our licensed partner pharmacies, listed on our pharmacy partners page.
See how tirzepatide treatment works at Surfbound.
Safety considerations
Brand-name GLP-1 medications have FDA-reviewed safety data from large randomized controlled trials; compounded versions have not undergone this review. However, FDA registration of a facility is not the same as FDA approval.
Prescriptions are filled by the pharmacy partners listed on our pharmacy partners page. It is important to understand that compounded medications carry different regulatory oversight than FDA-approved products. A Surfbound provider can discuss these differences with you during the review process.
If you are also weighing a non-GLP-1 medication, our compounded tirzepatide vs Zepbound cost comparison explains how those costs differ and where compounded GLP-1 fits.
Cost comparison
Access pathways compared by product type and price structure
| Access pathway | What it is | What determines cost | Regulatory status |
|---|---|---|---|
| Brand-name, no coverage | FDA-approved Wegovy or Zepbound purchased outside a manufacturer program | Manufacturer-set price that varies by product, form, strength, and pharmacy | FDA-approved, with large randomized trial data |
| Brand-name, with insurance coverage | The same FDA-approved products filled through a plan that covers them | Your plan's formulary; prior authorization, step therapy, and quantity limits are common | FDA-approved, though copay levels vary by plan and cannot be reduced to one figure |
| Compounded via telehealth | Compounded semaglutide or tirzepatide from a licensed compounding pharmacy | Surfbound charges $169 (semaglutide) or $219 (tirzepatide) per month, flat at every dose | Not FDA-approved; not a generic equivalent |
Cost depends on coverage, dose, and pharmacy. Brand-name figures are the manufacturer's standard self-pay prices: $349/month for the Wegovy injection, $149-$299/month for Wegovy pills depending on strength, and $299-$699/month for the Zepbound KwikPen depending on dose. They are set by the manufacturer and can change. | Compounded medications are not FDA-approved and are prepared by licensed compounding pharmacies.
Ready to take the next step?
See pricing and start your intakeFrequently asked questions
No. Compounded tirzepatide is not FDA-approved, is not a generic, and has not gone through FDA review for safety, effectiveness, or quality. It is prepared by a state-licensed pharmacy for one patient with a prescription. Zepbound is the FDA-approved brand-name product.
$219 a month, the same price at every prescribed dose. That includes the provider review, the medication if prescribed, and shipping. There is no membership fee. Compounded semaglutide is $169 a month.
A compounded medication can be prescribed for an individual patient when a licensed provider decides it is appropriate and it is permitted under federal and state law. FDA has limited compounding of copies of commercially available drugs. FDA's compounding guidance is linked in Sources.
The provider makes this determination based on your individual circumstances. Compounded medications may be prescribed for an individual patient when clinically appropriate and permitted under applicable federal and state law.
Licensed compounding pharmacies are registered with their state board of pharmacy. Prescriptions are filled by the pharmacy partners listed on our pharmacy partners page.
Surfbound operates on a cash-pay model with transparent pricing that does not require insurance.
Sources
This guide is published by Surfbound Health (Organization). It is educational content, not medical advice, and it does not replace an individual evaluation by a licensed provider.
Sources
- FDA: Compounding policies as GLP-1 supply stabilizes
- FDA: Proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list (April 30, 2026)
- FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 2026)
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- Zepbound (tirzepatide) prescribing information (current version)
Want more evidence-based health research from Surfbound?
Add Surfbound as a Preferred Source on Google